Navigation Links
Fixed C-Arms Revolutionize Operating Room Environments
Date:2/21/2008

US market for fixed C-arms to grow over 5% annually over the next five

years, according to Millennium Research Group

WALTHAM, Mass., Feb. 21 /PRNewswire/ -- According to Millennium Research Group's Global Markets for C-Arms 2008 report, the US market for fixed C-arm systems, comprising units used for cardiology, angiography, and neuroradiology procedures, was valued at over $1.4 billion in 2007 and will rise to over $1.8 billion by 2012.

In the US, several hospitals have begun using fixed C-arms in operating room (OR) environments. This trend has emerged as a result of the physician movement towards collaborative surgeries, in which many specialists work together to perform complex procedures. The installation of a C-arm system in the OR allows for the ideal imaging environment for this approach.

"A fixed C-arm offers the advanced imaging capabilities required to treat many complex procedures," says Ryan Goren, Analyst at Millennium Research Group. "These systems provide surgeons with the best imaging experience possible when performing complex interventional procedures, such as interventional cardiology and interventional radiology."

The Global Markets for C-Arms report includes coverage of US, Europe (France, Germany, Italy, and the UK), and Asia Pacific (Japan, China, India, Singapore, South Korea, and Taiwan). The report provides coverage of all key industry competitors, including GE Healthcare, Philips Healthcare, Siemens Healthcare, Toshiba Healthcare, and Shimadzu.

About C-Arms

Fixed C-arms are X-ray systems used in complex angiography, cardiology, and neuroradiology procedures. Single-plane systems consist of a single C-arm, while biplane systems comprise two C-arms mounted at a 90-degree angle in relation to each other. Fixed C-arm systems are used to guide surgeons performing interventional procedures. Modern flat-panel detector systems provide surgeons with superior image quality when performing complex, time-sensitive procedures.

About Millennium Research Group

Millennium Research Group (http://www.MRG.net), a Decision Resources, Inc. company (http://www.DecisionResources.com), is the global authority on medical technology market intelligence and a leading provider of strategic information to the health care sector. Focused solely on the medical device, pharmaceutical, and biotechnology industries, the company provides its clients with the benefits of its specialized industry expertise through published reports and customized consulting services.

All company, brand, or product names contained in this document may be

trademarks or registered trademarks of their respective holders

For more information, contact:

Amy Krohn

Millennium Research Group

416-364-7776 x101

akrohn@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates
2. Novel Angiogenic Drugs, Including a Future Blockbuster from Genzyme, Could Revolutionize Treatment of Peripheral Arterial Disease
3. 3-D photonic crystals will revolutionize telecommunications
4. Siemens New S Class Revolutionizes the Paradigm of Ultrasound Workflow Today and Tomorrow
5. Nanotechnology innovation may revolutionize gene detection in a single cell
6. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
7. Millennium Biotechnologies Group, Inc. (MBTG.OB) Announces Appointment of Mark C. Mirken as its President and Chief Operating Officer
8. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
9. Novo Nordisk Increased Operating Profit by 11% in the First Nine Months of 2007 Based on a 9% Sales Increase and an Improved Gross Margin
10. Ardea Biosciences, Inc. Reports Third Quarter 2007 Operating and Financial Results
11. Isis Announces Appointment of B. Lynne Parshall as Chief Operating Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/15/2017)... ... February 15, 2017 , ... ... and Chief Commercial Officer with GenePeeks. Matt is a veteran life sciences ... a computational genomics company focused on identifying inherited disease risk in future generations. ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. („TRIANNI") ... Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung der ... führenden Plattform für die Entdeckung monoklonaler Antikörper. ... neuartiges chimäres Gensegmentdesign aus, das Janssen den ... Antikörpern bietet und das für die schelle Isolierung ...
(Date:2/15/2017)... 15, 2017  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... the fourth quarter and full year ended December ... year for Vanda as we continued to demonstrate ... long-term exclusivity for Fanapt," said Mihael H. Polymeropoulos, ... emerging pipeline with important 2017 milestones underscores Vanda,s ...
(Date:2/15/2017)... , Feb. 15, 2017 Windtree Therapeutics, ... focused on developing aerosolized KL4 surfactant therapies for respiratory ... a slide presentation) at 8:00 AM EST on Thursday, ... phase 2 clinical program, the recently announced closing of ... development activities. To participate in the live ...
Breaking Biology Technology:
(Date:1/19/2017)... 19, 2017 Sensory Inc ., ... security for consumer electronics, and i ... and cybersecurity solutions, today announced a global partnership ... institutions worldwide to bolster security of data sensitive ... user authentication platforms they offer, innerCore now offers ...
(Date:1/18/2017)... MINNETONKA, Minn. , Jan. 18, 2017 /PRNewswire/ ... eClinical technology company that supports the entire spectrum ... 2016 has been another record-breaking year for the ... and market interest in MedNet,s eClinical products and ... to the tremendous marketplace success of ...
(Date:1/12/2017)... , Jan. 12, 2017  Trovagene, Inc. (NASDAQ: ... (ctDNA) technologies, today announced that it has signed agreements ... and the Middle East ... milestone marks the first wave of international distribution agreements ... and blood samples. The initial partners will ...
Breaking Biology News(10 mins):